Local recurrences are more common after abdominoperineal excision (APE) than after anterior resection of rectal cancer. Extralevator APE was introduced to address this problem. This prospective registry-based population study aims to investigate the efficacy of extralevator APE (ELAPE) in improving short-term oncological outcome.
The aim of this prospective registry-based population study was to investigate the efficacy of extralevator abdominoperineal excision (ELAPE) regarding local recurrence rates within 3 years after surgery. Local recurrence of rectal cancer is more common after abdominoperineal excision (APE) than after anterior resection. Extralevator abdominoperineal excision was introduced to address this problem. No large-scale studies with long-term oncological outcomes have been published. All Swedish patients operated on with an APE and registered in the Swedish ColoRectal Cancer Registry 2007 to 2009 were included (n = 1397) and analyzed with emphasis on the perineal part of the operation. Local recurrence at 3 years was collected from the registry. The local recurrence rates at 3 years [median follow-up, 3.43 years (APE, 3.37 years; ELAPE, 3.41 years; not stated: 3.43 years)] were significantly higher for ELAPE compared with APE (relative risk, 4.91). Perioperative perforation was also associated with an increased risk of local recurrence (relative risk, 3.62). There was no difference in 3-year overall survival between APE and ELAPE. In the subgroup of patients with very low tumors (≤4 cm from the anal verge), no significant difference in the local recurrence rate could be observed. Extralevator abdominoperineal excision results in a significantly increased 3-year local recurrence rate as compared with standard APE. Intraoperative perforation seems to be an important risk factor for local recurrence. In addition to significantly increased 3-year local recurrence rates, the significantly increased incidence of wound complications leads to the conclusion that ELAPE should only be considered in selected patients at risk of intraoperative perforation.
Aim: The aim of this study was to explore urogenital dysfunction and associated risk factors after treatment of rectal cancer, in a large national cohort of patients 3 years after abdominoperineal excision, and to compare outcomes with a reference population and a cohort of patients operated for prostate cancer.Method: Patients treated with abdominoperineal excision in 2007–2009 were identified using the Swedish Colorectal Cancer Registry. All consenting patients received a questionnaire. A sample of the Swedish population was contacted and completed a questionnaire. Patients undergoing radical prostatectomy in a prospective multicentre trial received questionnaires 24 months after surgery.Results: In the abdominoperineal excision, reference and radical prostatectomy populations 72%, 51% and 91% of the questionnaires were returned. Within the abdominoperineal excision group 36% of the men and 57% of the women were incontinent postoperatively. Fifteen per cent and 37% of men and women in the reference group were incontinent. Two years after radical prostatectomy 49% were incontinent. Seventy‐four per cent of the men had erectile dysfunction after abdominoperineal excision. Nineteen per cent of the women experienced reduced ability to reach orgasm. Fewer men and women experienced their present sex life as satisfying after abdominoperineal excision for rectal cancer compared with the reference population.Conclusion: A large proportion of patients endure persistent urogenital dysfunction after abdominoperineal excision for rectal cancer as do men after radical prostatectomy. Effects on sexual and urinary function should be part of preoperative information and after surgery patients should be asked about function in order to identify those in need of further assistance.
Background and Objectives: Frailty is a prognostic factor of post‐operative death and complications following colorectal cancer surgery. Frailty assessment is not routinely performed, hence, the prevalence is unknown. The aim of this study was to establish the presence of frailty in patients aged ≥ 70 years, and to analyse differences in post‐operative outcome comparing frail and non‐frail elderly patients.Method: Data of patients aged ≥ 70 years who underwent colorectal cancer surgery during 2016–2020 were retrospectively obtained from the Swedish Colorectal Cancer Registry. A cohort of 500 patients was assessed for frailty using the Clinical Frailty Scale (CFS‐9). Post‐operative mortality rates, complications, readmissions, and length of stay (LOS) were compared between frail and non‐frail patients.Results: The prevalence of frailty (CFS‐9 score ≥ 4) was 56%. The 90‐day mortality rate was higher in frail patients (OR 4.97 [95% CI 1.06–23.28], p 0.042), as well as 1‐year mortality (OR 4.39 [95% CI 1.86–10.34], p 0.0007). Frail patients had longer post‐operative LOS (7.63 vs. 11.0 days, p < 0.001), were more often treated in ICU and more often discharged to a nursing home.Conclusion: Frailty is a common condition in patients ≥ 70 years and a significant risk factor of post‐operative mortality and morbidity.
Background: Colorectal cancer (CRC) is the third most common cancer worldwide, with a median age of 72–75 years at diagnosis. Curative treatment usually involves surgery; if left untreated, symptoms may require emergency surgery. Therefore, most patients will be accepted for surgery, despite of high age or comorbidity. It is known that elderly patients suffer higher risks after surgery than younger patients, in terms of complications and mortality. Assessing frailty and offering frail elderly patients individualized treatment according to the comprehensive geriatric assessment (CGA) and care concept has been shown to improve the outcome for frail elderly patients in other clinical contexts.Methods: This randomized controlled multicentre trial aims to investigate if CGA and care prior to curatively intended surgery for CRC in frail elderly patients will improve postoperative outcome. All patients ≥ 70 years with surgically curable CRC will be screened for frailty using the Clinical Frailty Scale (CFS-9). Frail patients will be offered inclusion. Randomization is stratified for colon or rectal cancer. Patients in the intervention group are, in addition to standard protocol, treated according to CGA and care. This consists of individualized assessments and interventions, established by a multiprofessional team. Patients in the control group are treated according to best known practice as stipulated by Swedish colorectal cancer treatment guidelines, within an enhanced recovery after surgery (ERAS) setting. The primary outcome is 90-day mortality. Secondary outcomes are the length of hospital stay and total number of hospital days within 3 months, discharge destination, 30-day readmission, ADL, safe medication assessment, CFS-9 score, complications, Health-Related Quality of Life (HRQoL) at 2-month follow-up in comparison to baseline measurements, health economical calculations including cost-effectiveness analysis based on costs of hospital care and primary care, mortality and HRQoL at baseline, 2- and 12-month follow-up and all-cause 1-year mortality.Discussion: The trial is the first of its size and extent to investigate intervention with CGA and care prior to surgery for CRC in frail elderly patients. If this addition proves to be favourable, it could have implications on future care of frail elderly patients with CRC.Trial registration: ClinicalTrials.govNCT04358328. Registered on 4 February 2020
Background: Comprehensive geriatric assessment (CGA) and care has shown benefits for frail older adults across various care settings. However, its integration into routine care within a surgical context remains limited. An ongoing randomised controlled multicentre study will evaluate the effects of a period of preoperative optimisation (up to eight weeks), involving interprofessional CGA and care, in addition to routine care before colorectal cancer resection surgery. If this approach proves favourable, it could potentially be incorporated into routine surgical care. To facilitate implementation, it is crucial to explore and understand participants’ perceptions of taking part in a preoperative CGA and care intervention. Aim: To describe how frail older adults with colorectal cancer experience participation in a preoperative CGA and care intervention. Methods: This qualitative, descriptive study was part of a randomised controlled multi-centre study. In total, 20 semi-structured interviews were conducted with frail older adults undergoing a CGA and care intervention before colorectal cancer surgery. The data were analysed using inductive qualitative content analysis. Results: Frail older adults with colorectal cancer experienced participation in preoperative CGA and care as an integral part of an intervention. They adopted an opportunity mindset when deciding to participate. Throughout the intervention, they observed the team working collaboratively and actively involving them in the optimisation process, enhancing their readiness for surgery by the end of the period. Conclusions: The findings indicated that frail older adults with colorectal cancer viewed the preoperative CGA and care intervention as a meaningful opportunity for improvement and a chance to extend life. Their active involvement and the collaborative efforts of the care team during the intervention were crucial in enhancing their understanding, manageability, and readiness for surgery. They valued the opportunity to make active choices when appropriate and appreciated having the right to delegate decisions to healthcare professionals. From a frail older adult’s perspective, team-based approaches in preoperative care, such as CGA and care, offer benefits in terms of involvement and satisfaction. However, the thorough evaluation of postoperative outcomes remains necessary. Trial registration: OSF registry: https://osf.io/ch49n, registered on Sep 04, 2023.